XML 24 R12.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Investments
 3 Months Ended
Jun. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]  
Investments Investments
The Company’s investments consist of equity method investments primarily related to (i) investments in the StepStone Funds for which it serves as general partner or managing member but does not have a controlling financial interest and (ii) investments of Consolidated Funds. The Company’s equity interest in its equity method investments in the StepStone Funds typically does not exceed 1% in each fund. The Company’s share of the underlying net income or loss attributable to its equity interest in the funds is recorded in investment income in the condensed consolidated statements of income. Investment income attributable to the Consolidated Funds is recorded in investment income of Consolidated Funds. Investment income attributable to investments in certain legacy Greenspring funds for which the Company has no direct economic interests is recorded in legacy Greenspring investment income in the condensed consolidated statements of income.
Equity Method Investments
The Company’s equity method investments consist of the following:
As of
June 30, 2024March 31, 2024
Investments in funds(1)
$145,519 $135,043 
Accrued carried interest allocations1,328,853 1,354,051 
Legacy Greenspring investments in funds and accrued carried interest allocations(2)
617,539 631,197 
Total equity method investments$2,091,911 $2,120,291 
_______________________________
(1)The Company’s investments in funds were $217.9 million and $204.8 million as of June 30, 2024 and March 31, 2024, respectively. The consolidation of the Consolidated Funds results in the elimination of the Company’s investments in such funds.
(2)Reflects investments in funds of $147.5 million and $147.0 million and carried interest allocations of $470.0 million and $484.2 million as of June 30, 2024 and March 31, 2024, respectively.
The Company recognized equity method income (loss) of the following:
Three Months Ended June 30,
20242023
Carried interest allocations$16,634 $63,837 
Investment income2,595 3,086 
Legacy Greenspring carried interest allocations(9,089)(23,947)
Legacy Greenspring investment loss(1,255)(2,866)
Total equity method income$8,885 $40,110 
The decrease in carried interest allocations for the three months ended June 30, 2024 as compared to the three months ended June 30, 2023 was primarily attributable to lower net unrealized appreciation in the fair value of the underlying investments in the Company’s private equity funds. See note 2 for a discussion of the Company’s accounting policy for investments on a three-month lag.
As of June 30, 2024 and March 31, 2024, the Company’s investments in one and two SMAs, respectively, each individually represented 10% or more of the total accrued carried interest allocations balance, and in the aggregate represented approximately 15% and 26%, respectively, of the total accrued carried interest allocations balance as of those dates. As of June 30, 2024 and March 31, 2024, the Company’s investments in three commingled funds each individually represented 10% or more of the total legacy Greenspring accrued carried interest allocations balance, and in the aggregate represented approximately 37% and 36%, respectively, of the total legacy Greenspring accrued carried interest allocations balances as of those dates.
Of the total accrued carried interest allocations balance as of June 30, 2024 and March 31, 2024, $652.1 million and $719.5 million, respectively, were payable to affiliates and are included in accrued carried interest-related compensation in the condensed consolidated balance sheets. Of the total legacy Greenspring investments in funds and accrued carried interest allocations balance as of June 30, 2024 and March 31, 2024, $470.0 million and $484.2 million, respectively, were payable to employees who are considered affiliates of the Company and are included in legacy Greenspring accrued carried interest-related compensation in the condensed consolidated balance sheets and $147.5 million and $147.0 million, respectively, are reflected as non-controlling interests in legacy Greenspring entities in the condensed consolidated balance sheets.
The Company evaluates each of its equity method investments to determine if any are considered significant as defined by the SEC. As of June 30, 2024 and March 31, 2024 and for the three months ended June 30, 2024 and 2023, no individual equity method investment held by the Company met the significance criteria. As a result, the Company is not required to provide separate financial statements for any of its equity method investments.
Investments of Consolidated Funds
The Company consolidates funds and entities when it is deemed to hold a controlling financial interest. The activity of the Consolidated Funds is reflected within the condensed consolidated financial statements.
Investments held by the Consolidated Funds are summarized below:
Fair Value as ofPercentage of Total Investments as of
June 30, 2024March 31, 2024June 30, 2024March 31, 2024
Investments of Consolidated Funds:
Equity securities (cost of $21.9 million and $15.6 million as of June 30, 2024 and March 31, 2024, respectively)
$24,553 $17,028 16 %13 %
Partnership and LLC interests (cost of $93.3 million and $76.0 million as of June 30, 2024 and March 31, 2024, respectively)
133,669 114,830 84 %87 %
Total investments of Consolidated Funds$158,222 $131,858 100 %100 %
As of June 30, 2024 and March 31, 2024, no individual investment had a fair value greater than 5% of the Company’s total assets.
The following table summarizes the net realized and unrealized gains (losses) from investment activities of the Consolidated Funds:
Three Months Ended June 30,
20242023
Investments of Consolidated Funds:
Net realized gains on investments$327 $— 
Net unrealized gains on investments
7,308 2,362